Post-traumatic osteoarthritis(PTOA)is a complex and painful problem in the foot and ankle.Ninety percent of osteoarthritis cases in the foot and ankle can be classified as post-traumatic.PTOA can affect any of the 33 ...Post-traumatic osteoarthritis(PTOA)is a complex and painful problem in the foot and ankle.Ninety percent of osteoarthritis cases in the foot and ankle can be classified as post-traumatic.PTOA can affect any of the 33 joints in the foot and the ankle.Distraction arthroplasty is a method for treatment of early arthritic joints without fusing or replacing them and its effectiveness has been well documented.The purpose of this case series is to present our successful experiences and positive results using distraction arthroplasty to treat PTOA in the ankle,subtalar,first metatarsophalangeal,and second tarsometatarsal joints,and to present distraction arthroplasty as a viable alternative to invasive joint sacrificing procedures such as arthrodesis or arthroplasty.Distraction Arthroplasty effectively and safely treats PTOA and improves the stability of joints in the Foot and Ankle.Additionally,the use of bone marrow aspirate concentrate as an adjuvant can improve the long-term functional and structural outcomes of the joint,and can prolong the need for further,more aggressive surgical interventions such as fusion or arthroplasty.展开更多
目的观察关节镜手术治疗踝关节骨折后创伤性关节炎的近期效果。方法 2007年12月～2009年4月我院对17例踝关节骨折术后创伤性关节炎进行踝关节镜手术治疗,并运用关节镜观察踝关节病变情况。结果术中踝关节镜下见慢性滑膜炎性增生17例,胫...目的观察关节镜手术治疗踝关节骨折后创伤性关节炎的近期效果。方法 2007年12月～2009年4月我院对17例踝关节骨折术后创伤性关节炎进行踝关节镜手术治疗,并运用关节镜观察踝关节病变情况。结果术中踝关节镜下见慢性滑膜炎性增生17例,胫骨下端前缘骨赘6例,距骨颈部骨赘4例,距骨关节软骨损伤11例,胫骨关节软骨损伤4例,游离体2例。术后48 h 5例有关节疼痛、轻度肿胀1,周后好转,余无明显关节疼痛。16例随访12～25个月,平均18.2个月。根据Baird等踝关节评分系统评定疗效,优4例,良10例,可2例,优良率87.5%。结论踝关节镜手术治疗踝关节骨折后创伤性关节炎近期效果满意。展开更多
目的探讨玻璃酸钠关节腔内注射治疗踝关节创伤性关节炎的临床疗效及安全性。方法选择踝关节创伤性关节炎患者38例（共45个踝关节）,均给予2 m L玻璃酸钠关节腔内注射,1次/周,连续治疗5周。采用美国矫形外科足踝协会（AOFAS）评分标准对...目的探讨玻璃酸钠关节腔内注射治疗踝关节创伤性关节炎的临床疗效及安全性。方法选择踝关节创伤性关节炎患者38例（共45个踝关节）,均给予2 m L玻璃酸钠关节腔内注射,1次/周,连续治疗5周。采用美国矫形外科足踝协会（AOFAS）评分标准对治疗前后的关节疼痛、功能及自主活动等进行评定,并根据AOFAS最后得分分为优秀、良好、合格及差4个级别。治疗后定期进行踝关节X线正侧位摄片检查,观察是否达到影像学愈合标准,结合AOFAS分级及影像学检查结果进行疗效评价。治疗期间,严密观察患者并发症发生情况。结果治疗后,患者AOFAS总分及疼痛、功能和自主活动及支撑情况、最大步行距离、地面步行、反常步态、踝-后足稳定性、足部对线及后足活动各个项目评分均较治疗前显著提高（P〈0.01）;AOFAS评分显示优良率为93.33%,X线摄片检查显示88.89%达到影像学愈合标准,临床有效率为88.89%。7.89%的患者在首次关节腔注射药物后出现关节酸胀感,治疗后1~3 d消失。结论玻璃酸钠关节腔内注射治疗踝关节创伤性关节炎安全有效,不良反应轻微,值得临床推广。展开更多
文摘Post-traumatic osteoarthritis(PTOA)is a complex and painful problem in the foot and ankle.Ninety percent of osteoarthritis cases in the foot and ankle can be classified as post-traumatic.PTOA can affect any of the 33 joints in the foot and the ankle.Distraction arthroplasty is a method for treatment of early arthritic joints without fusing or replacing them and its effectiveness has been well documented.The purpose of this case series is to present our successful experiences and positive results using distraction arthroplasty to treat PTOA in the ankle,subtalar,first metatarsophalangeal,and second tarsometatarsal joints,and to present distraction arthroplasty as a viable alternative to invasive joint sacrificing procedures such as arthrodesis or arthroplasty.Distraction Arthroplasty effectively and safely treats PTOA and improves the stability of joints in the Foot and Ankle.Additionally,the use of bone marrow aspirate concentrate as an adjuvant can improve the long-term functional and structural outcomes of the joint,and can prolong the need for further,more aggressive surgical interventions such as fusion or arthroplasty.
文摘目的观察关节镜手术治疗踝关节骨折后创伤性关节炎的近期效果。方法 2007年12月～2009年4月我院对17例踝关节骨折术后创伤性关节炎进行踝关节镜手术治疗,并运用关节镜观察踝关节病变情况。结果术中踝关节镜下见慢性滑膜炎性增生17例,胫骨下端前缘骨赘6例,距骨颈部骨赘4例,距骨关节软骨损伤11例,胫骨关节软骨损伤4例,游离体2例。术后48 h 5例有关节疼痛、轻度肿胀1,周后好转,余无明显关节疼痛。16例随访12～25个月,平均18.2个月。根据Baird等踝关节评分系统评定疗效,优4例,良10例,可2例,优良率87.5%。结论踝关节镜手术治疗踝关节骨折后创伤性关节炎近期效果满意。
文摘目的探讨玻璃酸钠关节腔内注射治疗踝关节创伤性关节炎的临床疗效及安全性。方法选择踝关节创伤性关节炎患者38例（共45个踝关节）,均给予2 m L玻璃酸钠关节腔内注射,1次/周,连续治疗5周。采用美国矫形外科足踝协会（AOFAS）评分标准对治疗前后的关节疼痛、功能及自主活动等进行评定,并根据AOFAS最后得分分为优秀、良好、合格及差4个级别。治疗后定期进行踝关节X线正侧位摄片检查,观察是否达到影像学愈合标准,结合AOFAS分级及影像学检查结果进行疗效评价。治疗期间,严密观察患者并发症发生情况。结果治疗后,患者AOFAS总分及疼痛、功能和自主活动及支撑情况、最大步行距离、地面步行、反常步态、踝-后足稳定性、足部对线及后足活动各个项目评分均较治疗前显著提高（P〈0.01）;AOFAS评分显示优良率为93.33%,X线摄片检查显示88.89%达到影像学愈合标准,临床有效率为88.89%。7.89%的患者在首次关节腔注射药物后出现关节酸胀感,治疗后1~3 d消失。结论玻璃酸钠关节腔内注射治疗踝关节创伤性关节炎安全有效,不良反应轻微,值得临床推广。
